STING1 and cancer: This STING-dependent interferon signaling can initially facilitate immune activation; however chronic STING pathway activation and/or IFN-γ signaling can ultimately lead to T cell exhaustion via PD-L1-dependent resistance to anti-tumor immunity (70), potentiating cancer immune escape.